Cargando…

Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses

The emergence of H5, H7, and H9 avian influenza virus subtypes in humans reveals their pandemic potential. Although human-to-human transmission has been limited, the genetic reassortment of the avian and human/porcine influenza viruses or mutations in some of the genes resulting in virus replication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Ahmed O., Amen, Omar, Sayedahmed, Ekramy E., Vemula, Sai V., Amoah, Samuel, York, Ian, Gangappa, Shivaprakash, Sambhara, Suryaprakash, Mittal, Suresh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638338/ https://www.ncbi.nlm.nih.gov/pubmed/29023601 http://dx.doi.org/10.1371/journal.pone.0186244

Ejemplares similares

A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose
por: Sayedahmed, Ekramy E., et al.
Publicado: (2018)

Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
por: Pandey, Aseem, et al.
Publicado: (2012)

Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI(®) induces enhanced serological, cellular and protective immune responses
por: Cao, Weiping, et al.
Publicado: (2018)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
por: Sayedahmed, Ekramy E., et al.
Publicado: (2020)

Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
por: Elkashif, Ahmed, et al.
Publicado: (2021)

Progress towards the Development of a Universal Influenza Vaccine
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness
por: Vemula, Sai V., et al.
Publicado: (2013)

Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice
por: Cao, Weiping, et al.
Publicado: (2017)

Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases
por: Alhashimi, Marwa, et al.
Publicado: (2021)

5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication
por: Ranjan, Priya, et al.
Publicado: (2010)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Influenza Virus Infects and Depletes Activated Adaptive Immune Responders
por: Bohannon, Caitlin D., et al.
Publicado: (2021)

Patients Hospitalized with pH1N1 Influenza in an Academic Community Medical Center
por: Bergman, Hagit, et al.
Publicado: (2011)

Development of nonhuman adenoviruses as vaccine vectors
por: Bangari, Dinesh S., et al.
Publicado: (2006)

Mapping Antibody Epitopes of the Avian H5N1 Influenza Virus
por: Yen, Hui-Ling, et al.
Publicado: (2009)

A Dual-Functioning 5ʹ-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1
por: Singh, Neetu, et al.
Publicado: (2020)

Influenza virus exploits tunneling nanotubes for cell-to-cell spread
por: Kumar, Amrita, et al.
Publicado: (2017)

Adenovirus-based vaccines against avian-origin H5N1 influenza viruses
por: He, Biao, et al.
Publicado: (2015)

A Porcine Adenovirus with Low Human Seroprevalence Is a Promising Alternative Vaccine Vector to Human Adenovirus 5 in an H5N1 Virus Disease Model
por: Patel, Ami, et al.
Publicado: (2010)

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
por: Kim, Jin Hyang, et al.
Publicado: (2016)

Innate lymphoid cells (ILC) in SARS-CoV-2 infection()
por: Kumar, Amrita, et al.
Publicado: (2021)

Glycan Masking of Hemagglutinin for Adenovirus Vector and Recombinant Protein Immunizations Elicits Broadly Neutralizing Antibodies against H5N1 Avian Influenza Viruses
por: Lin, Shih-Chang, et al.
Publicado: (2014)

The 3′ Untranslated Regions of Influenza Genomic Sequences Are 5′PPP-Independent Ligands for RIG-I
por: Davis, William G., et al.
Publicado: (2012)

Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine
por: Sayedahmed, Ekramy E., et al.
Publicado: (2023)

Identification of a Dual-Specific T Cell Epitope of the Hemagglutinin Antigen of an H5 Avian Influenza Virus in Chickens
por: Haghighi, Hamid R., et al.
Publicado: (2009)

T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response
por: Moise, Leonard, et al.
Publicado: (2018)

The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses
por: Sutton, Troy C.
Publicado: (2018)

Suppression effect of recombinant adenovirus vector containing hIL-24 on Hep-2 laryngeal carcinoma cells
por: CHEN, XUEMEI, et al.
Publicado: (2014)

Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge
por: Cox, Freek, et al.
Publicado: (2015)

DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice
por: Epstein, Suzanne L., et al.
Publicado: (2002)

Molecular characterization and three-dimensional structures of avian H8, H11, H14, H15 and swine H4 influenza virus hemagglutinins
por: Yang, Hua, et al.
Publicado: (2020)

Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1
por: Nfon, Charles, et al.
Publicado: (2012)

Stepwise prediction and statistical screening: B-cell epitopes on neuraminidase of human avian H(5)N(1) virus
por: Huang, Ping, et al.
Publicado: (2008)

Identification of NP Protein-Specific B-Cell Epitopes for H9N2 Subtype of Avian Influenza Virus
por: Huang, Xiangyu, et al.
Publicado: (2022)

Covalent decoration of adenovirus vector capsids with the carbohydrate epitope αGal does not improve vector immunogenicity, but allows to study the in vivo fate of adenovirus immunocomplexes
por: Kratzer, Ramona F., et al.
Publicado: (2017)

NADPH Oxidase 1 Is Associated with Altered Host Survival and T Cell Phenotypes after Influenza A Virus Infection in Mice
por: Hofstetter, Amelia R., et al.
Publicado: (2016)

Comparative Serological Assays for the Study of H5 and H7 Avian Influenza Viruses
por: Molesti, Eleonora, et al.
Publicado: (2013)

Susceptibility of swine to H5 and H7 low pathogenic avian influenza viruses
por: Balzli, Charles, et al.
Publicado: (2016)

Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus Vaccines
por: Lin, Shih-Chang, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6ip6c1bifh1jg5v2jcdp1r5g6b